MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Total Liabilities Summary of MIRA Pharmaceuticals, Inc.

  • MIRA Pharmaceuticals, Inc.'s latest annual total liabilities in 2023 was 558.09 Thousand USD , down -61.62% from previous year.
  • MIRA Pharmaceuticals, Inc.'s latest quarterly total liabilities in 2024 Q2 was 796.61 Thousand USD , up 22.18% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported annual total liabilities of 1.45 Million USD in 2022, up 32.96% from previous year.
  • MIRA Pharmaceuticals, Inc. reported annual total liabilities of 1.09 Million USD in 2021, up 1110.44% from previous year.
  • MIRA Pharmaceuticals, Inc. reported quarterly total liabilities of 796.61 Thousand USD for 2024 Q2, up 22.18% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported quarterly total liabilities of 558.09 Thousand USD for 2023 FY, down -61.62% from previous quarter.

Annual Total Liabilities Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Total Liabilities of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 558.09 Thousand USD -61.62%
2022 1.45 Million USD 32.96%
2021 1.09 Million USD 1110.44%
2020 90.36 Thousand USD 0.0%

Peer Total Liabilities Comparison of MIRA Pharmaceuticals, Inc.

Name Total Liabilities Total Liabilities Difference
Amgen Inc. 90.92 Billion USD 99.999%
AstraZeneca PLC 61.95 Billion USD 99.999%
Biogen Inc. 12.04 Billion USD 99.995%
Gilead Sciences, Inc. 39.37 Billion USD 99.999%
Scilex Holding Company 274.24 Million USD 99.796%
Scilex Holding Company 274.24 Million USD 99.796%